Lexaria Bioscience概述了其2026年研发计划,目的是提高药物提供技术,扩大临床和商业应用。 Lexaria Bioscience outlines its 2026 R&D plan to boost drug delivery tech and expand clinical and commercial applications.

Lexaria生物科学公司公布了其2026年研究和开发战略,重点是推广其专有的脱水TECH交付技术,以提高消费品中活性化合物的生物利用率。 Lexaria Bioscience Corp. has unveiled its 2026 research and development strategy, focusing on advancing its proprietary DehydraTECH delivery technology to enhance the bioavailability of active compounds in consumer products. 该公司计划扩大临床测试,探索健康和药品方面的新应用,并加强伙伴关系以支持产品开发和监管途径。 The company plans to expand clinical testing, explore new applications in wellness and pharmaceuticals, and strengthen partnerships to support product development and regulatory pathways.